Hospitals & Diagnostic Centres Stocks
32 NSE-listed hospitals & diagnostic centres companies, largest first, with each one's stage, price and valuation after the close.
32
companies
7 (22%)
in a Stage 2 uptrend
-6.9%
3-month return, weighted by size
0 · 12 · 9
in Stage 1 · 3 · 4
Only the Stage 2 ones →Filter them in the screener →All Health Care stocks →Industry rotation →
Every hospitals & diagnostic centres stock we track
| Stock | Stage | Close | Day | 3 months | From high | RS | P/E | Yield | Market cap |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSPApollo Hospitals Enterprise | Stage 3, wk 5 | ₹8,599.50 | +1.9% | -5.0% | -5.2% | 75 | 58.2 | 0.24% | ₹1.24L Cr |
| MAXHEALTHMax Healthcare Institute | Stage 4, wk 5 | ₹927.15 | +3.5% | -13.9% | -22.1% | 41 | 65.2 | 0.22% | ₹90,242 Cr |
| MANIPALHOSManipal Health Enterprises | — | ₹667.20 | +3.9% | — | — | — | 135.8 | — | ₹87,762 Cr |
| ASTERDMAster DM Healthcare | Stage 3, wk 7 | ₹719.55 | +5.6% | -13.8% | -17.3% | 71 | 110.4 | 0.44% | ₹62,649 Cr |
| FORTISFortis Healthcare | Stage 4, wk 5 | ₹790.65 | +0.6% | -15.2% | -25.1% | 36 | 56.6 | 0.13% | ₹59,691 Cr |
| NHNarayana Hrudayalaya | Stage 4, wk 4 | ₹1,931.50 | +3.3% | +0.6% | -7.2% | 75 | 45.1 | 0.23% | ₹39,229 Cr |
| MEDANTAGlobal Health | Stage 3, wk 3 | ₹1,402.00 | +5.7% | -2.3% | -7.1% | 71 | 67.7 | 0.04% | ₹37,651 Cr |
| LALPATHLABDr. Lal PathLabs | Stage 2, wk 21 | ₹2,029.40 | +5.4% | +7.4% | 0.0% | 85 | 59.0 | 0.84% | ₹33,934 Cr |
| KIMSKrishna Institute of Medical Sciences | Stage 3, wk 8 | ₹740.55 | +1.4% | -7.0% | -12.9% | 70 | 144.1 | — | ₹31,104 Cr |
| AGARWALEYEDr. Agarwal's Health Care | Stage 3, wk 3 | ₹523.50 | +2.1% | +6.1% | -6.6% | 69 | 110.3 | — | ₹16,597 Cr |
| VIJAYAVijaya Diagnostic Centre | Stage 2, wk 25 | ₹1,424.60 | -1.6% | +2.9% | -9.3% | 88 | 78.1 | 0.14% | ₹14,673 Cr |
| RAINBOWRainbow Children's Medicare | Stage 3, wk 5 | ₹1,279.60 | +2.7% | -19.0% | -20.0% | 61 | 44.3 | 0.27% | ₹12,945 Cr |
| METROPOLISMetropolis Healthcare | Stage 3, wk 4 | ₹581.25 | +2.2% | -0.6% | -3.5% | 80 | 56.7 | 0.36% | ₹12,059 Cr |
| PARKHOSPSPark Medi World | Stage 3, wk 4 | ₹230.45 | +3.0% | -18.8% | — | — | 35.1 | — | ₹9,954 Cr |
| YATHARTHYatharth Hospital & Trauma Care Services | Stage 2, wk 26 | ₹1,027.90 | +4.7% | +21.6% | -11.6% | 84 | 54.7 | 0.05% | ₹9,904 Cr |
| HCGHealthcare Global Enterprises | Stage 3, wk 3 | ₹621.35 | +1.6% | -7.6% | -20.0% | 51 | 395.1 | — | ₹9,277 Cr |
| JLHLJupiter Life Line Hospitals | Stage 4, wk 1 | ₹279.55 | +6.3% | -13.1% | -15.9% | 56 | 48.3 | 0.08% | ₹9,164 Cr |
| THYROCAREThyrocare Technologies | Stage 3, wk 4 | ₹495.50 | +2.6% | -18.1% | -23.7% | 77 | 53.8 | 1.43% | ₹7,887 Cr |
| KOVAIKovai Medical Center & Hospital | — | ₹5,995.00 | +1.8% | — | — | — | 25.6 | 0.25% | ₹6,560 Cr |
| NEPHROPLUSNephrocare Health Services | Stage 3, wk 3 | ₹622.35 | -0.4% | -12.7% | — | — | 69.8 | — | ₹6,258 Cr |
| INDRAMEDCOIndraprastha Medical Corporation | Stage 4, wk 24 | ₹336.30 | +5.6% | -9.2% | -46.0% | 15 | 15.7 | 1.24% | ₹3,083 Cr |
| DRAGARWQDr Agarwals Eye Hospital | Stage 2, wk 11 | ₹5,423.00 | +2.9% | +6.7% | -5.8% | 72 | 33.2 | 0.08% | ₹2,621 Cr |
| KMCSHILK M C Speciality Hospitals (India) | Stage 2, wk 53 | ₹150.46 | +0.6% | +19.2% | -17.9% | 96 | 44.0 | — | ₹2,454 Cr |
| SURAKSHASuraksha Diagnostic | Stage 2, wk 9 | ₹333.05 | +2.9% | +32.6% | -6.4% | 70 | 47.9 | 0.15% | ₹1,735 Cr |
| KRSNAAKrsnaa Diagnostics | Stage 4, wk 2 | ₹483.05 | -0.6% | -14.1% | -41.6% | 17 | 16.3 | 0.41% | ₹1,645 Cr |
| SHALBYShalby | Stage 4, wk 12 | ₹122.70 | -0.3% | -25.7% | -50.0% | 8 | 35.3 | — | ₹1,319 Cr |
| GKSLGujarat Kidney and Super Speciality | Stage 2, wk 3 | ₹159.71 | -0.8% | +22.3% | — | — | 63.4 | — | ₹1,259 Cr |
| GPTHEALTHGPT Healthcare | Stage 3, wk 4 | ₹141.04 | +2.5% | -13.0% | -17.3% | 62 | 23.9 | 1.82% | ₹1,157 Cr |
| MAXINDMax India | Stage 4, wk 9 | ₹146.86 | +1.7% | -14.5% | -31.4% | 29 | — | — | ₹827 Cr |
| GAUDIUMIVFGaudium IVF and Women Health | — | ₹107.22 | -0.7% | -18.8% | — | — | 31.9 | — | ₹780 Cr |
| MOMSBELIEFRays of Belief | — | ₹251.36 | +1.5% | — | — | — | 63.2 | — | ₹525 Cr |
| LOTUSEYELotus Eye Hospital and Institute | Stage 4, wk 7 | ₹106.52 | -2.0% | -8.6% | -24.7% | 55 | 1350.0 | — | ₹222 Cr |
Hospitals & Diagnostic Centres Stocks: quick answers
How many hospitals & diagnostic centres stocks are in an uptrend?
As of 4 Nov 2026, 7 of the 32 NSE-listed hospitals & diagnostic centres stocks we track are in Stage 2, the uptrend phase, including Dr. Lal PathLabs (LALPATHLAB), Vijaya Diagnostic Centre (VIJAYA), Yatharth Hospital & Trauma Care Services (YATHARTH), Dr Agarwals Eye Hospital (DRAGARWQ) and K M C Speciality Hospitals (India) (KMCSHIL).
What is the largest hospitals & diagnostic centres stock?
Apollo Hospitals Enterprise (APOLLOHOSP), with a market value of ₹1.24L Cr. It closed at ₹8,599.50 on 4 Nov 2026, in Stage 3.
Which hospitals & diagnostic centres stocks are near their 52-week high?
As of 4 Nov 2026, 2 are within 5% of a 52-week high: Dr. Lal PathLabs (LALPATHLAB) and Metropolis Healthcare (METROPOLIS).